Dr. Fabrizia Bonacina
Area of expertise: dyslipidemia, atherosclerosis, adaptive immune response and T lymphocytes
Dr. Bonacina is Assistant Professor of Pharmacology at the University of Milan (Italy). She obtained the PhD at the University of Milan working on inflammation in cardiometabolic diseases, then she moved to the Cardiovascular Immunology Lab at the Queen Mary University of London, where she investigated Tcell activation under dyslipidemia.
Combining the expertise on lipid metabolism and immune response, the goal of her current research is to identify novel molecular targets to prevent immune-inflammatory activation in cardio-metabolic diseases taking advantage from humanized models.
Dr. Bonacina received inter/and national awards and grants (Cariplo and Roche Foundations, Ministry of University and Research) for her work and is member of the European Lipoprotein Club OC and of the Young Fellows of the European Atherosclerosis Society.
Dr Romain Capoulade
Area of expertise: pathophysiology of valvular heart diseases.
Dr Romain Capoulade obtained his PhD in Experimental Medicine from Laval University in Québec, Canada in 2014, where he investigated the metabolic determinants associated with the development of calcific aortic valve stenosis. He pursued his career at the Massachusetts General Hospital, Harvard Medical School in Boston, working on pathologies affecting the mitral valve.
Following these two international experiences, Romain joined the INSERM U1087 laboratory in Nantes, France, and developed a research program focused on the understanding and characterization of cellular and molecular mechanisms involved in the development and progression of heart valve diseases. His research is supported by national (ANR, French Society of Cardiology, French Federation of Cardiology) and European grants (ERA-CVD, Marie Sklodowska Curie IF). In 2020, he was elected as a member of the young researcher nucleus at the French research group on cardiovascular diseases and implemented actions dedicated to young scientists working in the field.
Our mission: To reduce the burden of cardiovascular disease.